-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Amgen, Raises Price Target to $440

Benzinga·08/05/2026 20:54:01
语音播报
UBS analyst Michael Yee maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $420 to $440.